Published on: November 29, 2017 at 10:30PM
Conditions: Head and Neck Cancer; Advanced Cancer; Metastatic Cancer
Intervention: Drug: Abemaciclib
Sponsor: Centre Leon Berard
Not yet recruiting
http://ift.tt/2AiIUVH
New cancer clinical trial: Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6
Tag: cancer Clinical Trials
No comments: